Mark Perloe, Retired Physician, Self-employed Script Writer, shared on LinkedIn:
“Prostate Forum is seeking physician and clinical expert speakers for a series of online educational forums addressing key issues in prostate cancer diagnosis, risk stratification, treatment selection, and survivorship decision-making.
We are particularly interested in speakers who can provide balanced, evidence-based perspectives that extend beyond a single commercial product, treatment modality, or institutional interest. Presentations should be clinically rigorous while accessible to patients, caregivers, and other members of the prostate cancer community.
Topics of interest include:
The influence of age on prostate cancer decision-making:
How chronological age, physiologic age, comorbidity burden, life expectancy, functional status, disease risk category, and patient preferences should inform diagnostic and treatment decisions.
Travel for prostate cancer treatment:
When referral to a high-volume or specialized center may be appropriate; considerations involving multidisciplinary care, access to clinical trials, advanced imaging, complex surgery, radiation planning, and continuity of local follow-up.
Personalized medicine and androgen-deprivation therapy:
How tumor biology, disease burden, genomic and germline testing, biomarkers, treatment sequencing, adverse-effect profiles, and patient-specific clinical factors affect decisions regarding ADT and treatment intensification.
Second-opinion review of prostate biopsy pathology:
Indications for expert genitourinary pathology review; potential implications for Gleason Grade Group assignment, risk stratification, treatment planning, and confidence in active-surveillance decisions.
Prostate cancer and ‘paralysis by analysis’:
Helping patients navigate uncertainty, conflicting information, multiple reasonable treatment options, decisional regret, and the practical role of shared decision-making.
If you have expertise in one or more of these areas – or can recommend a colleague who may be interested in participating – please contact me.
We welcome recommendations for urologists, radiation oncologists, medical oncologists, genitourinary pathologists, geriatricians, genetic counselors, advanced practice clinicians, behavioral-health professionals, and other qualified members of the multidisciplinary prostate cancer care team.
You can also read: Chemotherapy in Prostate Cancer: Current Evidence and Clinical Applications
